Lipocine
LPCN
LPCN
50 hedge funds and large institutions have $28.9M invested in Lipocine in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
14% less funds holding
Funds holding: 58 → 50 (-8)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
50
Holding in Top 10
–
Calls
$430K
Puts
$313K
Top Buyers
| 1 | +$3.8M | |
| 2 | +$285K | |
| 3 | +$256K | |
| 4 |
PP
PDT Partners
New York
|
+$186K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$162K |
Top Sellers
| 1 | -$344K | |
| 2 | -$126K | |
| 3 | -$93K | |
| 4 |
SG Americas Securities
New York
|
-$71K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$49K |